Narrative intervention to disseminate ACT for depression in primary care

在初级保健中传播针对抑郁症的 ACT 的叙事干预

基本信息

  • 批准号:
    9220647
  • 负责人:
  • 金额:
    $ 17.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-01 至 2019-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The public health impact of existing treatments for depression is limited by our ability to disseminate those treatments. There is a particular need to find innovative ways to disseminate key principles of empirically supported psychotherapy in primary care settings. Over half of U.S. residents who receive mental health care receive it in primary care, and primary care can reach many who might not access psychiatric care due to perceived stigma or other barriers. Narrative communication is an alternative way to disseminate key principles of psychotherapy that catalyze behavior change. Narrative communication refers to "storytelling" -real people telling stories about their struggles and successful ways of coping. Narrative interventions can result in behavior change for other problems, such as hypertension. An advantage of narrative communication is that it can be easily distributed (by video), can be very engaging, and may reach people who do not have access to other technologies or who experience barriers to traditional psychotherapy. We propose that key principles of a type of cognitive-behavioral therapy (Acceptance and Commitment Therapy, or ACT) can be disseminated through a video storytelling intervention. ACT is an empirically-supported therapy for depression and related problems. Key principles for catalyzing behavior change and alleviating depression include: 1) striving for consistency between personal values and daily actions; 2) being more willing to experience negative thoughts/ feelings in the service of personal values; 3) viewing negative thoughts/feelings as transient; and 4) being more fully present (or mindful) in everyday life. There are two primary aims of this treatment development project. First, together with a video production firm, we will produce a storytelling video intervention (sTVi), with real primary care patients discussing their own (ACT-consistent) successful coping strategies. Using an iterative process, we will create 4 30-minute "episodes" intended to be viewed over the course of a month; we will also create an accompanying workbook. Second, we will conduct a) a small open trial (n = 10) of sTVi and b) pilot randomized controlled trial (n = 40) with depressed primary care patients receiving antidepressant medication treatment as usual (TAU) + sTVi vs. TAU + attention control videos. Assessments will occur at baseline and 4 and 12 weeks. We will examine feasibility and acceptability of sTVi (by examining uptake and completion of sTVi, whether the videos are considered engaging, and whether viewers understand key ACT principles and see them as relevant to their lives) and of the RCT research design. We will examine treatment differences (within relevant confidence intervals) on outcomes (e.g., depression). We will examine change in hypothesized mechanisms, i.e., ACT-consistent coping strategies. The next step in this line of research is to test, in a large- scale randomized controlled trial, the efficacy of sTVi as an adjunct to antidepressant medication in depressed primary care patients, and to examine ACT-consistent coping strategies as mechanisms of action.
描述(由申请人提供):现有的抑郁症治疗方法对公共卫生的影响受到我们传播这些治疗方法的能力的限制。有一个特别的需要

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Development of a Storytelling Video Self-Help Intervention Based on Acceptance and Commitment Therapy for Major Depression: Open Trial Results.
基于接受和承诺疗法的重度抑郁症讲故事视频自助干预的开发:公开试验结果。
  • DOI:
    10.1177/0145445517738932
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Gaudiano,BrandonA;Davis,CarterH;Miller,IvanW;Uebelacker,LisaA
  • 通讯作者:
    Uebelacker,LisaA
Pilot randomized controlled trial of a video self-help intervention for depression based on acceptance and commitment therapy: Feasibility and acceptability.
基于接受和承诺疗法的抑郁症视频自助干预的试点随机对照试验:可行性和可接受性。
  • DOI:
    10.1002/cpp.2436
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Gaudiano,BrandonA;Davis,CarterH;Miller,IvanW;Uebelacker,Lisa
  • 通讯作者:
    Uebelacker,Lisa
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRANDON A GAUDIANO其他文献

BRANDON A GAUDIANO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRANDON A GAUDIANO', 18)}}的其他基金

Effectiveness of a multi-component mHealth intervention to improve post-hospital transitions of care for patients with SMI
多组成部分移动医疗干预对改善 SMI 患者出院后护理过渡的有效性
  • 批准号:
    10502609
  • 财政年份:
    2022
  • 资助金额:
    $ 17.67万
  • 项目类别:
Development of an adjunctive video-based suicide prevention intervention immediately following psychiatric hospitalization
在精神病院住院后立即开发基于视频的辅助自杀预防干预措施
  • 批准号:
    10296677
  • 财政年份:
    2020
  • 资助金额:
    $ 17.67万
  • 项目类别:
Development of an adjunctive video-based suicide prevention intervention immediately following psychiatric hospitalization
在精神病院住院后立即开发基于视频的辅助自杀预防干预措施
  • 批准号:
    9894972
  • 财政年份:
    2020
  • 资助金额:
    $ 17.67万
  • 项目类别:
RCT to Improve Post-Hospital Treatment Adherence for Comorbid Substance Use and Bipolar Disorders
随机对照试验可提高共病药物使用和双相情感障碍的出院后治疗依从性
  • 批准号:
    10456650
  • 财政年份:
    2019
  • 资助金额:
    $ 17.67万
  • 项目类别:
RCT to Improve Post-Hospital Treatment Adherence for Comorbid Substance Use and Bipolar Disorders
随机对照试验可提高共病药物使用和双相情感障碍的出院后治疗依从性
  • 批准号:
    10015339
  • 财政年份:
    2019
  • 资助金额:
    $ 17.67万
  • 项目类别:
RCT to Improve Post-Hospital Treatment Adherence for Comorbid Substance Use and Bipolar Disorders
随机对照试验可提高共病药物使用和双相情感障碍的出院后治疗依从性
  • 批准号:
    10218024
  • 财政年份:
    2019
  • 资助金额:
    $ 17.67万
  • 项目类别:
Mobile After-Care Support Intervention for Patients with Schizophrenia following Hospitalization
精神分裂症患者住院后的移动善后支持干预
  • 批准号:
    9924664
  • 财政年份:
    2018
  • 资助金额:
    $ 17.67万
  • 项目类别:
Narrative intervention to disseminate ACT for depression in primary care
在初级保健中传播针对抑郁症的 ACT 的叙事干预
  • 批准号:
    9002100
  • 财政年份:
    2015
  • 资助金额:
    $ 17.67万
  • 项目类别:
Effectiveness of Psychosocial Treatment for Inpatients with Psychosis
心理社会治疗对住院精神病患者的有效性
  • 批准号:
    8696880
  • 财政年份:
    2013
  • 资助金额:
    $ 17.67万
  • 项目类别:
Technology-Assisted Assessment of Post-Hospital Adherence in Schizophrenia
精神分裂症出院后依从性的技术辅助评估
  • 批准号:
    8703805
  • 财政年份:
    2013
  • 资助金额:
    $ 17.67万
  • 项目类别:

相似海外基金

The role of antihypertensive agents in renal and vascular complications in a model of hypertension and diabetes
抗高血压药物在高血压和糖尿病模型中肾脏和血管并发症中的作用
  • 批准号:
    nhmrc : 145854
  • 财政年份:
    2001
  • 资助金额:
    $ 17.67万
  • 项目类别:
    NHMRC Postgraduate Scholarships
APPROACHES TO NATRIURETIC AND ANTIHYPERTENSIVE AGENTS
利尿钠和抗高血压药物的治疗方法
  • 批准号:
    6125791
  • 财政年份:
    1997
  • 资助金额:
    $ 17.67万
  • 项目类别:
APPROACHES TO NATRIURETIC AND ANTIHYPERTENSIVE AGENTS
利尿钠和抗高血压药物的治疗方法
  • 批准号:
    2487342
  • 财政年份:
    1997
  • 资助金额:
    $ 17.67万
  • 项目类别:
APPROACHES TO NATRIURETIC AND ANTIHYPERTENSIVE AGENTS
利尿钠和抗高血压药物的治疗方法
  • 批准号:
    2839029
  • 财政年份:
    1997
  • 资助金额:
    $ 17.67万
  • 项目类别:
APPROACHES TO NATRIURETIC AND ANTIHYPERTENSIVE AGENTS
利尿钠和抗高血压药物的治疗方法
  • 批准号:
    6330091
  • 财政年份:
    1997
  • 资助金额:
    $ 17.67万
  • 项目类别:
ANTIHYPERTENSIVE AGENTS FROM RANUNCULACEAE
毛茛科抗高血压药
  • 批准号:
    2217036
  • 财政年份:
    1993
  • 资助金额:
    $ 17.67万
  • 项目类别:
ANTIHYPERTENSIVE AGENTS FROM RANUNCULACEAE
毛茛科抗高血压药
  • 批准号:
    3343932
  • 财政年份:
    1993
  • 资助金额:
    $ 17.67万
  • 项目类别:
ANTIHYPERTENSIVE AGENTS FROM RANUNCULACEAE
毛茛科抗高血压药
  • 批准号:
    2217037
  • 财政年份:
    1993
  • 资助金额:
    $ 17.67万
  • 项目类别:
CANNABINOIDS AS ANTIHYPERTENSIVE AGENTS
大麻素作为抗高血压药
  • 批准号:
    3500707
  • 财政年份:
    1985
  • 资助金额:
    $ 17.67万
  • 项目类别:
Antihypertensive Agents of Kudzu: Possible Chemical Utilization of a Southeastern Pest Vine
葛根的抗高血压剂:东南部害虫藤蔓的可能化学利用
  • 批准号:
    7905238
  • 财政年份:
    1979
  • 资助金额:
    $ 17.67万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了